Jones Day advised Royalty Pharma on the deal.Royalty Pharma have acquired a $500m interest in PureTech’s royalty in Karuna Therapeutics’ KarXT, with $100m cash up front…
PureTech Health and Royalty Pharma’s KarXT Royalty Agreement
Jones Day advised Royalty Pharma on the deal.Royalty Pharma have acquired a $500m interest in PureTech’s royalty in Karuna Therapeutics’ KarXT, with $100m cash up front…